These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19167101)

  • 21. [Aspirin resistance].
    Yilmaz MB; Balbay Y; Korkmaz S
    Anadolu Kardiyol Derg; 2004 Mar; 4(1):59-62. PubMed ID: 15033621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability in platelet response to the antiplatelet agents aspirin and clopidogrel: mechanisms, measurement, and clinical relevance.
    Jennings LK
    Crit Pathw Cardiol; 2009 Mar; 8(1):20-8. PubMed ID: 19258834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin "resistance".
    Zimmermann N; Weber AA; Hohlfeld T
    Herz; 2008 Jun; 33(4):270-8. PubMed ID: 18581076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin resistance: does it exist?
    Rao GH; Michiels JJ
    Semin Thromb Hemost; 2007 Mar; 33(2):210-4. PubMed ID: 17340471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical appraisal of the phenomenon of aspirin resistance.
    Svenstrup Poulsen T; Kristensen SR; Atar D; Mickley H
    Cardiology; 2005; 104(2):83-91. PubMed ID: 16020925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology.
    Kuliczkowski W; Witkowski A; Polonski L; Watala C; Filipiak K; Budaj A; Golanski J; Sitkiewicz D; Pregowski J; Gorski J; Zembala M; Opolski G; Huber K; Arnesen H; Kristensen SD; De Caterina R
    Eur Heart J; 2009 Feb; 30(4):426-35. PubMed ID: 19174428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
    Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric assessment of platelet aspirin resistance using light scattering.
    Won DI; Yang DH; Kim DH; Chae SC; Suh JS
    Cytometry B Clin Cytom; 2008 Mar; 74(2):110-7. PubMed ID: 18061948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetics of aspirin resistance.
    Goodman T; Sharma P; Ferro A
    Int J Clin Pract; 2007 May; 61(5):826-34. PubMed ID: 17391325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.
    Ben-Dor I; Kleiman NS; Lev E
    Am J Cardiol; 2009 Jul; 104(2):227-33. PubMed ID: 19576352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring the antiplatelet action of aspirin.
    Fritsma GA; Ens GE; Alvord MA; Carroll AA; Jensen R
    JAAPA; 2001 May; 14(5):57-8, 61-2. PubMed ID: 11523339
    [No Abstract]   [Full Text] [Related]  

  • 32. Report: frequency of aspirin resistance in patients with coronory artery disease in Pakistan.
    Akhtar N; Junaid A; Khalid A; Ahmed W; Shah MA; Rahman H
    Pak J Pharm Sci; 2009 Apr; 22(2):230-3. PubMed ID: 19339237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
    Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update.
    Di Minno MN; Lupoli R; Palmieri NM; Russolillo A; Buonauro A; Di Minno G
    Thromb Res; 2012 Mar; 129(3):341-4. PubMed ID: 22142668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug insight: aspirin resistance-fact or fashion?
    Maree AO; Cox D; Fitzgerald DJ
    Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):E1; author reply E2. PubMed ID: 17330121
    [No Abstract]   [Full Text] [Related]  

  • 36. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
    Guha S; Sardar P; Guha P; Roy S; Mookerjee S; Chakrabarti P; Deb PK; Chaudhuri U; Deb S; Karmakar R; Dasgupta AK; Lahiri P
    Indian Heart J; 2009; 61(1):68-73. PubMed ID: 19729693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to antiplatelet therapy: fact or fiction?
    Wong S; Lewis D
    N Z Med J; 2005 May; 118(1215):U1459. PubMed ID: 15915183
    [No Abstract]   [Full Text] [Related]  

  • 39. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin.
    Evangelista V; Manarini S; Di Santo A; Capone ML; Ricciotti E; Di Francesco L; Tacconelli S; Sacchetti A; D'Angelo S; Scilimati A; Sciulli MG; Patrignani P
    Circ Res; 2006 Mar; 98(5):593-5. PubMed ID: 16484611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.
    Pettinella C; Romano M; Stuppia L; Santilli F; Liani R; Davì G
    Thromb Haemost; 2009 Apr; 101(4):687-90. PubMed ID: 19350112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.